Livforsakringsbolaget Skandia’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $134K | Hold |
612
| – | – | 0.01% | 453 |
|
|
2025
Q1 | $137K | Hold |
612
| – | – | 0.01% | 455 |
|
|
2024
Q4 | $200K | Buy |
+612
| New | +$200K | 0.01% | 393 |
|
|
2024
Q3 | – | Sell |
-190
| Closed | -$62.6K | – | 615 |
|
|
2024
Q2 | $62.6K | Hold |
190
| – | – | 0.01% | 350 |
|
|
2024
Q1 | $75.1K | Hold |
190
| – | – | 0.01% | 346 |
|
|
2023
Q4 | $66.9K | Buy |
190
+90
| +90% | +$31.7K | 0.01% | 356 |
|
|
2023
Q3 | $37.5K | Hold |
100
| – | – | ﹤0.01% | 358 |
|
|
2023
Q2 | $38.2K | Hold |
100
| – | – | ﹤0.01% | 370 |
|
|
2023
Q1 | $34.6K | Hold |
100
| – | – | ﹤0.01% | 396 |
|
|
2022
Q4 | $23.5K | Hold |
100
| – | – | ﹤0.01% | 448 |
|
|
2022
Q3 | $25K | Sell |
100
-400
| -80% | -$100K | ﹤0.01% | 433 |
|
|
2022
Q2 | $151K | Sell |
500
-200
| -29% | -$60.4K | 0.01% | 386 |
|
|
2022
Q1 | $287K | Hold |
700
| – | – | 0.02% | 378 |
|
|
2021
Q4 | $328K | Sell |
700
-700
| -50% | -$328K | 0.02% | 372 |
|
|
2021
Q3 | $594K | Hold |
1,400
| – | – | 0.04% | 305 |
|
|
2021
Q2 | $503K | Buy |
1,400
+600
| +75% | +$216K | 0.03% | 349 |
|
|
2021
Q1 | $225K | Hold |
800
| – | – | 0.02% | 452 |
|
|
2020
Q4 | $227K | Hold |
800
| – | – | 0.02% | 434 |
|
|
2020
Q3 | $220K | Hold |
800
| – | – | 0.02% | 374 |
|
|
2020
Q2 | $182K | Hold |
800
| – | – | 0.02% | 404 |
|
|
2020
Q1 | $122K | Buy |
800
+200
| +33% | +$30.5K | 0.02% | 435 |
|
|
2019
Q4 | $90K | Buy |
+600
| New | +$90K | 0.01% | 537 |
|